These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 15531933

  • 1. High-dose statin and COX-2 inhibitor therapy rapidly decreases C-reactive protein level in patients with unstable angina.
    Chyrchel M, Dudek D, Bartuś S, Legutko J, Heba G, Dubiel JS.
    Kardiol Pol; 2004 Sep; 61(9):213-21; discussion 222-4. PubMed ID: 15531933
    [Abstract] [Full Text] [Related]

  • 2. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial.
    Ray KK, Cannon CP, Cairns R, Morrow DA, Rifai N, Kirtane AJ, McCabe CH, Skene AM, Gibson CM, Ridker PM, Braunwald E, PROVE IT-TIMI 22 Investigators.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1417-24. PubMed ID: 16226164
    [Abstract] [Full Text] [Related]

  • 3. High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering Study Investigators.
    Circulation; 2003 Sep 30; 108(13):1560-6. PubMed ID: 12975259
    [Abstract] [Full Text] [Related]

  • 4. Effects of high-dose statin administered prior to coronary angioplasty on the incidence of cardiac events in patients with acute coronary syndrome.
    Chyrchel M, Rakowski T, Rzeszutko L, Legutko J, Dziewierz A, Dubiel JS, Dudek D.
    Kardiol Pol; 2006 Dec 30; 64(12):1357-62; discussion 1363. PubMed ID: 17206539
    [Abstract] [Full Text] [Related]

  • 5. Increased C-reactive protein level after coronary stent implantation in patients with stable coronary artery disease.
    Almagor M, Keren A, Banai S.
    Am Heart J; 2003 Feb 30; 145(2):248-53. PubMed ID: 12595841
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Impact of prolonged cyclooxygenase-2 inhibition on inflammatory markers and endothelial function in patients with ischemic heart disease and raised C-reactive protein: a randomized placebo-controlled study.
    Bogaty P, Brophy JM, Noel M, Boyer L, Simard S, Bertrand F, Dagenais GR.
    Circulation; 2004 Aug 24; 110(8):934-9. PubMed ID: 15302800
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials).
    Murphy SA, Cannon CP, Wiviott SD, de Lemos JA, Blazing MA, McCabe CH, Califf RM, Braunwald E.
    Am J Cardiol; 2007 Oct 01; 100(7):1047-51. PubMed ID: 17884359
    [Abstract] [Full Text] [Related]

  • 10. Effects of early administration of atorvastatin treatment on thrombotic process in normocholesterolemic patients with unstable angina.
    Tousoulis D, Bosinakou E, Kotsopoulou M, Antoniades C, Katsi V, Stefanadis C.
    Int J Cardiol; 2006 Jan 26; 106(3):333-7. PubMed ID: 16337041
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pregnancy-associated plasma protein-A elevation in patients with acute coronary syndrome and subsequent atorvastatin therapy.
    Miedema MD, Conover CA, MacDonald H, Harrington SC, Oberg D, Wilson D, Henry TD, Schwartz RS.
    Am J Cardiol; 2008 Jan 01; 101(1):35-9. PubMed ID: 18157962
    [Abstract] [Full Text] [Related]

  • 13. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome.
    Chen YG, Xu F, Zhang Y, Ji QS, Sun Y, Lü RJ, Li RJ.
    Chin Med J (Engl); 2006 Jan 05; 119(1):32-6. PubMed ID: 16454979
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Inflammation, statin therapy, and risk of stroke after an acute coronary syndrome in the MIRACL study.
    Kinlay S, Schwartz GG, Olsson AG, Rifai N, Szarek M, Waters DD, Libby P, Ganz P, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Arterioscler Thromb Vasc Biol; 2008 Jan 05; 28(1):142-7. PubMed ID: 17991875
    [Abstract] [Full Text] [Related]

  • 16. Statin therapy may prevent restenosis after successful coronary intervention, independent of lipid-lowering effect and CRP level.
    Yamawaki T, Yamada A, Fukumoto Y, Kishi T, Sobashima A, Kuwata K, Nakamura R, Sekiya M, Ando H, Okamatsu S.
    Fukuoka Igaku Zasshi; 2007 Jun 05; 98(6):260-9. PubMed ID: 17665547
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome.
    Zhou T, Zhou SH, Qi SS, Shen XQ, Zeng GF, Zhou HN.
    Clin Chim Acta; 2006 Jun 05; 368(1-2):168-72. PubMed ID: 16480969
    [Abstract] [Full Text] [Related]

  • 19. High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial.
    Tsimikas S, Witztum JL, Miller ER, Sasiela WJ, Szarek M, Olsson AG, Schwartz GG, Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study Investigators.
    Circulation; 2004 Sep 14; 110(11):1406-12. PubMed ID: 15353498
    [Abstract] [Full Text] [Related]

  • 20. Persistent activation of nuclear factor kappa-B signaling pathway in patients with unstable angina and elevated levels of C-reactive protein evidence for a direct proinflammatory effect of azide and lipopolysaccharide-free C-reactive protein on human monocytes via nuclear factor kappa-B activation.
    Liuzzo G, Santamaria M, Biasucci LM, Narducci M, Colafrancesco V, Porto A, Brugaletta S, Pinnelli M, Rizzello V, Maseri A, Crea F.
    J Am Coll Cardiol; 2007 Jan 16; 49(2):185-94. PubMed ID: 17222729
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.